GPBAR1 and breast cancer: LCA anticancer properties in relation to BC in general, include reductions in cancer cell proliferation and epithelial to mesenchymal cell transition inhibition acting via the G-protein-coupled bile acid receptor 1 (TGR5) that exerts downstream anti-inflammatory effects (104).